Cite
HARVARD Citation
Jacob, S. et al. (2022). Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial. Lancet. pp. 199-210. [Online].